TOKYO, Nov. 7, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 578 million (USD 4.0 million1) in four projects for the development of new diagnostics and drugs for neglected tropical diseases (NTDs) and malaria. 2
The increasing demand for clinical laboratory services is mainly driven by the rising prevalence of chronic and infectious diseases, lifestyle-related...
Global Women’s Health Therapeutics Market to Grow at 4.05% CAGR from 2024-2032, Fueled by Increased Focus on Reproductive Health, Menopause, and Breast...
As per Fortune Business Insights’ report, the U.S. hepatitis B vaccine Market share sector attained a worth of USD 2.49 Billion in 2022. Forecasts indicate a promising path, foreseeing a Compound…
The contact-lens induced infections industry is analyzed across different global regions, including Asia Pacific, North America, and Europe. In Asia...
This document has been translated from the Japanese original for reference purposes only.
In the event of any discrepancy between these translated documents and...
The biotechnology industry is experiencing significant growth, fueled by recent breakthroughs in drug development, technological innovations, and robust government support. Given this backdrop, promising biotech stocks Shionogi & Co. (SGIOY),...
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Antibacterial Drugs...
The global urinary tract infections therapeutics market size was valued at USD 8.92 billion in 2022. It is estimated to reach an expected value of USD...
North America held largest share of global cell therapy market, which was valued at USD 7,820.35 million in 2020 and is expected to grow at a CAGR of 4.5%...
/PRNewswire/ -- The global antibiotics market size is expected to reach USD 68.04 billion by 2030, registering a CAGR of 4.26% from 2023 to 2030, according to...